JP2024517807A5 - - Google Patents
Info
- Publication number
- JP2024517807A5 JP2024517807A5 JP2023567884A JP2023567884A JP2024517807A5 JP 2024517807 A5 JP2024517807 A5 JP 2024517807A5 JP 2023567884 A JP2023567884 A JP 2023567884A JP 2023567884 A JP2023567884 A JP 2023567884A JP 2024517807 A5 JP2024517807 A5 JP 2024517807A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- composition according
- different
- pharmaceutically acceptable
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184609P | 2021-05-05 | 2021-05-05 | |
| US63/184,609 | 2021-05-05 | ||
| PCT/US2022/027784 WO2022235874A1 (en) | 2021-05-05 | 2022-05-05 | Nucleotide and nucleoside therapeutic compositions, combinations and uses related thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517807A JP2024517807A (ja) | 2024-04-23 |
| JP2024517807A5 true JP2024517807A5 (cg-RX-API-DMAC7.html) | 2025-05-14 |
Family
ID=83932924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567884A Pending JP2024517807A (ja) | 2021-05-05 | 2022-05-05 | ヌクレオチド及びヌクレオシド治療組成物、組合せ、並びにそれらに関連する使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250281519A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4333859A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024517807A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117881402A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216679A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022235874A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116554249B (zh) * | 2022-01-28 | 2025-03-18 | 北京恩泰伟医药科技有限公司 | 抗病毒化合物及其用途 |
| CN116199730A (zh) * | 2023-04-24 | 2023-06-02 | 南京颐媛生物医学研究院有限公司 | 4-硫代尿嘧啶核糖核苷磷酸酯化合物及其制备方法和应用 |
| CN117567310A (zh) * | 2023-11-28 | 2024-02-20 | 重庆智合生物医药有限公司 | 一种神经酰胺np1的合成方法 |
| WO2026043895A1 (en) * | 2024-08-19 | 2026-02-26 | Altesa BioSciences, Inc. | Method of treating respiratory conditions in chronic obstructive pulmonary disease patients |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR213700A0 (en) * | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
| CN102046621B (zh) * | 2008-05-27 | 2014-11-12 | 生物区科学管理控股有限公司 | 抗病毒盐 |
| WO2011160191A1 (en) * | 2010-06-25 | 2011-12-29 | Biota Scientific Management Pty Ltd | Compound for the treatment of enteroviruses |
| TW201542581A (zh) * | 2013-09-11 | 2015-11-16 | 艾默理大學 | 核苷酸與核苷治療組成物及其相關用途 |
| WO2016145142A1 (en) * | 2015-03-10 | 2016-09-15 | Emory University | Nucleotide and nucleoside therapeutics compositions and uses related thereto |
| KR20260028884A (ko) * | 2018-03-07 | 2026-03-04 | 에모리 유니버시티 | 4'-할로겐 함유 뉴클레오티드 및 뉴클레오시드 치료 조성물 및 이와 관련된 용도 |
-
2022
- 2022-05-05 CA CA3216679A patent/CA3216679A1/en active Pending
- 2022-05-05 WO PCT/US2022/027784 patent/WO2022235874A1/en not_active Ceased
- 2022-05-05 CN CN202280043048.3A patent/CN117881402A/zh active Pending
- 2022-05-05 JP JP2023567884A patent/JP2024517807A/ja active Pending
- 2022-05-05 US US18/558,874 patent/US20250281519A1/en active Pending
- 2022-05-05 EP EP22799556.0A patent/EP4333859A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2486181C2 (ru) | Пиримидилциклопентаны как ингибиторы акт-протеинкиназ | |
| JP2024543976A5 (cg-RX-API-DMAC7.html) | ||
| JP2024520481A5 (cg-RX-API-DMAC7.html) | ||
| RU2475478C2 (ru) | Соединения для лечения пролиферативных расстройств | |
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| JP2019509276A5 (cg-RX-API-DMAC7.html) | ||
| RU2009102252A (ru) | Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с | |
| JP2017512191A5 (cg-RX-API-DMAC7.html) | ||
| JP2010533160A5 (cg-RX-API-DMAC7.html) | ||
| JP2013545816A5 (cg-RX-API-DMAC7.html) | ||
| CO5390079A1 (es) | Compuestos heterociclicos novedosos que tienen actividades hipolipidemicas, hipocolesterolicas, proceso para su preparacion y composiciones farmaceuticas que los contienen y su uso en medicina | |
| JP2014521688A5 (cg-RX-API-DMAC7.html) | ||
| JP2013545818A5 (cg-RX-API-DMAC7.html) | ||
| JP2013056886A5 (cg-RX-API-DMAC7.html) | ||
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| JP2013544812A5 (cg-RX-API-DMAC7.html) | ||
| RU2009132512A (ru) | Аналоги 2-5а и способы их применения | |
| RU2003137561A (ru) | 4-замещенные нуклеозиды | |
| EA201491180A1 (ru) | 4'-азидо,3'-фторзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк вируса гепатита с | |
| JP2014532716A5 (cg-RX-API-DMAC7.html) | ||
| JP2018522861A5 (cg-RX-API-DMAC7.html) | ||
| JP2021523108A5 (cg-RX-API-DMAC7.html) | ||
| RU2010145463A (ru) | Производные замещенного 2-фенилпиридина | |
| IL310611A (en) | Substituted arylmethylureas and heteroarylmethylureas, analogues thereof, and methods using same | |
| RU2006134022A (ru) | Производные индазола и содержащие их фармацевтические композиции |